Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Endra Life Sciences Inc (NQ: NDRA )

1.290 +0.090 (+7.50%)
Streaming Delayed Price Updated: 1:27 PM EST, Dec 5, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 47,187
Open 1.220
Bid (Size) 1.270 (10)
Ask (Size) 1.290 (7)
Prev. Close 1.200
Today's Range 1.190 - 1.320
52wk Range 0.8700 - 5.950
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
ENDRA Life Sciences Secures 39th U.S. Patent for TAEUS® System Technology
From ENDRA Life Sciences Inc.
Via Business Wire
ENDRA Life Sciences to Participate in The Benchmark Company’s 12th Annual Discovery One-on-One Investor Conference
From ENDRA Life Sciences Inc.
Via Business Wire

Performance

YTD
-69.65%
-69.65%
1 Month
+37.23%
+37.23%
3 Month
+18.48%
+18.48%
6 Month
-15.69%
-15.69%
1 Year
-63.14%
-63.14%

More News

Read More
ENDRA Life Sciences: Q3 Earnings Insights
Via Benzinga
ENDRA Life Sciences Reports Third Quarter 2023 Financial Results and Provides Business Update
From ENDRA Life Sciences Inc.
Via Business Wire
Earnings Preview: ENDRA Life Sciences
Via Benzinga
ENDRA Life Sciences Achieves Intellectual Property Milestone with Issuance of Three New Patents
From ENDRA Life Sciences Inc.
Via Business Wire
ENDRA Life Sciences to Report Third Quarter 2023 Financial Results on November 14, 2023
From ENDRA Life Sciences Inc.
Via Business Wire
ENDRA to Host Multidisciplinary Clinical Discussion on Managing Liver Disease During AASLD’s The Liver Meeting® 2023
From ENDRA Life Sciences Inc.
Via Business Wire
Why Novonix Shares Are Trading Higher By 27%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Via Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
Why Volcon Shares Are Trading Lower By 19%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
Via InvestorPlace
12 Health Care Stocks Moving In Thursday's After-Market Session
Via Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
Abstract for ENDRA Life Sciences' TAEUS System Accepted for Presentation at EASL Steatotic Liver Disease Summit 2023
From ENDRA Life Sciences Inc.
Via Business Wire
ENDRA Life Sciences' TAEUS De Novo Submission Advances to Next Stage of Review with FDA
From ENDRA Life Sciences Inc.
Via Business Wire
ENDRA Life Sciences Expands Intellectual Property with Issuance of U.S. and European Patents
From ENDRA Life Sciences Inc.
Via Business Wire
ENDRA Life Sciences Reports Second Quarter 2023 Financial Results and Provides a Business Update
From ENDRA Life Sciences Inc.
Via Business Wire
Why PhenomeX Are Trading Lower By Around 20%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Via Benzinga
ENDRA Life Sciences Submits De Novo Request for its TAEUS® System Liver Fat Application to the U.S. FDA
From ENDRA Life Sciences Inc.
Via Business Wire
Earnings Scheduled For August 14, 2023
Via Benzinga
ENDRA Life Sciences to Report Second Quarter 2023 Financial Results on August 14, 2023
From ENDRA Life Sciences Inc.
Via Business Wire
ENDRA Life Sciences Announces Adjournment of 2023 Annual Meeting of Stockholders to July 25, 2023
From ENDRA Life Sciences Inc.
Via Business Wire
Why Nocera Are Trading Higher By Around 89%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Study Highlighting ENDRA Life Sciences’ TAEUS Technology to be Presented at EASL International Liver Congress 2023
From ENDRA Life Sciences Inc.
Via Business Wire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.